Found 39 matching trials
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer PHASE2 PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Show More Learn More & Join Trial
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery PHASE3 This is a prospective, multicenter, randomized, open-label, phase III non-i...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer PHASE3 RATIONALE: Removing axillary lymph nodes may be effective in stopping the s...
Show More Location
Royal Prince Alfred Hospital, Sydney
Learn More & Join Trial
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment PHASE3 The purpose of this multi-centre, randomised, double-blind, parallel-group ...
Show More Learn More & Join Trial
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery PHASE2 Doctors leading this study would like to learn about providing cancer treat...
Show More Location
Lagos State University Teaching Hospital
Learn More & Join Trial
German Preoperative Adriamycin Docetaxel Study PHASE2 The primary objective of this trial is to determine the rate of pathologica...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer PHASE2 This is a one stage phase II study with a single arm design. It will be con...
Show More Status
Active Not Recruiting
Location
University College Hospital, Ibadan, Nigeria
Learn More & Join Trial
Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients PHASE2 MORE-T trial is designed to investigate the effect of Tamoxifen 40mg (vs. T...
Show More Status
Active Not Recruiting
Location
Seoul National University Hospital
Learn More & Join Trial
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer PHASE3 This study will evaluate the pharmacokinetics, efficacy, and safety of the ...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial PHASE2 Breast cancer is an optimal "model disease" for studying personalized medic...
Show More Status
Active Not Recruiting
Location
Akershus University Hospital
Learn More & Join Trial